Papers
1
Total Citations
33
H-Index
1
About
Dr. Rebecca Mull has made pivotal contributions to the field of high-throughput screening (HTS) through her pioneering work on cell-based functional assays. Her research focuses on optimizing cellular assay technologies, particularly addressing the critical challenge of maintaining consistent, viable cell supplies for large-scale drug discovery operations. Her most cited paper, "Application of Division Arrest Technology to Cell-Based HTS: Comparison with Frozen and Fresh Cells" (2005, 33 citations), demonstrates her innovative approach to improving assay reproducibility by comparing division-arrested cells with traditional frozen and fresh cell preparations. This work has provided practical solutions for HTS laboratories seeking to streamline screening workflows while maintaining cellular response consistency over extended periods. Dr. Mull's contributions have helped bridge the gap between emerging detection and automation technologies and the practical demands of day-to-day screening operations, enabling more reliable and scalable cell-based assays. Her research continues to influence the development of robust cellular models for pharmaceutical testing, making her a respected figure in the HTS community.
Research Focus
Key Achievements
Top Papers
- 1